John Lloyd

661 total citations
21 papers, 434 citations indexed

About

John Lloyd is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, John Lloyd has authored 21 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 6 papers in Organic Chemistry. Recurrent topics in John Lloyd's work include Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (12 papers) and Atrial Fibrillation Management and Outcomes (3 papers). John Lloyd is often cited by papers focused on Cardiac electrophysiology and arrhythmias (14 papers), Ion channel regulation and function (12 papers) and Atrial Fibrillation Management and Outcomes (3 papers). John Lloyd collaborates with scholars based in United States, Germany and Sweden. John Lloyd's co-authors include Paul Lévesque, Mary Lee Conder, Karnail S. Atwal, Heather J. Finlay, Tonya Jenkins-West, Christine Huang, Huabin Sun, Lin Yan, Tram Huynh and Wayne Vaccaro and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochimica et Biophysica Acta (BBA) - Bioenergetics and Bioorganic & Medicinal Chemistry.

In The Last Decade

John Lloyd

21 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lloyd United States 13 220 193 111 40 36 21 434
Christopher A. Teleha United States 13 393 1.8× 234 1.2× 66 0.6× 56 1.4× 28 0.8× 32 668
Anthony K. L. Fung United States 13 201 0.9× 273 1.4× 88 0.8× 18 0.5× 24 0.7× 20 456
Elizabeth M. Naylor United States 11 136 0.6× 152 0.8× 74 0.7× 8 0.2× 23 0.6× 16 320
W. J. GREENLEE United States 13 252 1.1× 296 1.5× 190 1.7× 19 0.5× 25 0.7× 21 573
Michael D. Dowle United Kingdom 9 364 1.7× 177 0.9× 52 0.5× 97 2.4× 21 0.6× 22 530
Berthold Narr Germany 8 196 0.9× 125 0.6× 139 1.3× 24 0.6× 36 1.0× 11 434
Zhengxiang Gu United States 11 327 1.5× 232 1.2× 42 0.4× 12 0.3× 17 0.5× 17 491
Shoji Fukumoto Japan 11 257 1.2× 155 0.8× 30 0.3× 32 0.8× 24 0.7× 14 395
Sarah C. Traeger United States 13 224 1.0× 149 0.8× 29 0.3× 21 0.5× 22 0.6× 26 464
Pascal Bouyssou France 12 331 1.5× 213 1.1× 29 0.3× 32 0.8× 10 0.3× 25 498

Countries citing papers authored by John Lloyd

Since Specialization
Citations

This map shows the geographic impact of John Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lloyd more than expected).

Fields of papers citing papers by John Lloyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lloyd. The network helps show where John Lloyd may publish in the future.

Co-authorship network of co-authors of John Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of John Lloyd. A scholar is included among the top collaborators of John Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lloyd. John Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finlay, Heather J., James A. Johnson, John Lloyd, et al.. (2016). Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a PotentIKurInhibitor. ACS Medicinal Chemistry Letters. 7(9). 831–834. 11 indexed citations
2.
Lloyd, John, Heather J. Finlay, James A. Johnson, et al.. (2015). Pseudosaccharin amines as potent and selective KV1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 25(21). 4983–4986. 5 indexed citations
3.
Johnson, James A., Ningning Xu, Yoon Jeon, et al.. (2014). Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(14). 3018–3022. 5 indexed citations
4.
Finlay, Heather J., Ji Jiang, Mary Lee Conder, et al.. (2013). Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 23(6). 1743–1747. 9 indexed citations
5.
Pi, Zulan, James Sutton, John Lloyd, et al.. (2013). 2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 23(14). 4206–4209. 16 indexed citations
6.
7.
Lloyd, John, Heather J. Finlay, Lin Yan, et al.. (2010). Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 20(4). 1436–1439. 81 indexed citations
8.
9.
Lloyd, John, Heather J. Finlay, Karnail S. Atwal, et al.. (2009). Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5469–5473. 35 indexed citations
10.
Vaccaro, Wayne, Tram Huynh, John Lloyd, et al.. (2008). Dihydropyrazolopyrimidine Inhibitors of KV1.5 (IKur). Bioorganic & Medicinal Chemistry Letters. 18(24). 6381–6385. 24 indexed citations
11.
Finlay, Heather J., et al.. (2008). Pyrano-[2,3b]-pyridines as potassium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 18(8). 2714–2718. 14 indexed citations
12.
Johnson, Stephen R., Hongwen Yue, Mary Lee Conder, et al.. (2007). Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR. Bioorganic & Medicinal Chemistry. 15(18). 6182–6192. 20 indexed citations
13.
Lloyd, John, Karnail S. Atwal, Heather J. Finlay, et al.. (2007). Benzopyran sulfonamides as KV1.5 potassium channel blockers. Bioorganic & Medicinal Chemistry Letters. 17(12). 3271–3275. 27 indexed citations
14.
Atwal, Karnail S., Saleem Ahmad, Charles Z. Ding, et al.. (2004). N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase. Bioorganic & Medicinal Chemistry Letters. 14(4). 1027–1030. 12 indexed citations
15.
Ahmad, Saleem, John D. DiMarco, Mary Lee Conder, et al.. (2003). Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs. Bioorganic & Medicinal Chemistry Letters. 14(1). 99–102. 11 indexed citations
16.
Lloyd, John, George C. Rovnyak, Saleem Ahmad, et al.. (2001). Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers. Journal of Medicinal Chemistry. 44(23). 3764–3767. 18 indexed citations
17.
Lloyd, John, et al.. (1996). Solid phase synthesis of phosphinic acid endothelin converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(12). 1323–1326. 24 indexed citations
18.
Lloyd, John, Denis E. Ryono, J. Eileen Bird, et al.. (1994). Quinoline-4-carboxylic acids as angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 195–200. 10 indexed citations
19.
Hwang, Dah‐Ren, W.C. Eckelman, C.J. Mathias, et al.. (1991). Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography.. PubMed. 32(9). 1730–7. 34 indexed citations
20.
Balcavage, Walter X., John Lloyd, J.R. Mattoon, Tomo̧ko Ohnishi, & Antonio Scarpa. (1973). Cation movements and respiratory response in yeast mitochondria treated with high Ca2+ concentrations. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 305(1). 41–51. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher A. Teleha Breakdown of academic impact, for papers by Anthony K. L. Fung Breakdown of academic impact, for papers by Elizabeth M. Naylor Breakdown of academic impact, for papers by W. J. GREENLEE Breakdown of academic impact, for papers by Michael D. Dowle Breakdown of academic impact, for papers by Berthold Narr Breakdown of academic impact, for papers by Zhengxiang Gu Breakdown of academic impact, for papers by Shoji Fukumoto Breakdown of academic impact, for papers by Sarah C. Traeger Breakdown of academic impact, for papers by Pascal Bouyssou
Rankless by CCL
2026